Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy
In the translational process of developing innovative therapies for DMD (Duchenne muscular dystrophy), the last preclinical validation step is often carried out in the most relevant animal model of this human disease, namely the GRMD (Golden Retriever muscular dystrophy) dog. The disease in GRMD dog...
Saved in:
Main Authors: | Inès Barthélémy (Author), Fernanda Pinto-Mariz (Author), Erica Yada (Author), Loïc Desquilbet (Author), Wilson Savino (Author), Suse Dayse Silva-Barbosa (Author), Anne-Marie Faussat (Author), Vincent Mouly (Author), Thomas Voit (Author), Stéphane Blot (Author), Gillian Butler-Browne (Author) |
---|---|
Format: | Book |
Published: |
The Company of Biologists,
2014-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Levels of α7 integrin and laminin-α2 are increased following prednisone treatment in the mdx mouse and GRMD dog models of Duchenne muscular dystrophy
by: Ryan D. Wuebbles, et al.
Published: (2013) -
Nitric Oxide (NO) and Duchenne Muscular Dystrophy: NO Way to Go?
by: Cara A. Timpani, et al.
Published: (2020) -
Improvement of Duchenne muscular dystrophy phenotype following obestatin treatment
by: Jessica González‐Sánchez, et al.
Published: (2018) -
Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (1989) -
Theragnosis for Duchenne Muscular Dystrophy
by: Leonela Luce, et al.
Published: (2021)